If you enjoy this content, please share it with a colleague
RELATED CONTENT
May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours ...
September 22, 2021 — Radiation therapy is an effective and widely used treatment for breast cancer. While the benefits ...
Aug. 10, 2017 — The American College of Radiology (ACR) developed three new guidance documents and revised 32 others to ...
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat cancer patients for the second leading cause of death among cancer survivors — cardiovascular disease brought on by their treatments. Specific types of chemotherapy and chest directed radiation therapy are known to cause cardiac dysfunction, mainly due to cardiotoxicity — the symptoms of which may not present until months or even years after cancer treatment.
New recommendations from the American College of Cardiology (ACC) and the American College of Radiology (ACR) have established appropriate use of diagnostic imaging for patients with chest pain, one of the most common reasons for emergency department visits.
A nationwide study published in the Journal of the American College of Cardiology identified current frequent barriers to cardio-oncology services in the United States. According to the study, many hospital training programs have no formal training or services in cardio-oncology, and a lack of national guidelines and funding also creates barriers.
September 30, 2014 — The American College of Cardiology (ACC), along with eight partnering societies, released the first appropriate use criteria (AUC) for suspected heart disease in pediatric patients.
August 18, 2014 — Two Mount Sinai research studies in the August issue of the Journal of the American College of Cardiology (ACC): Cardiovascular Imaging show the potential of using tele-robotic medicine when diagnosing heart failure patients.
A recent whitepaper by the Economist Intelligence Unit deems value in the “emerging new currency within health markets.” Since medical imaging represents a fairly large segment of the broader healthcare market and certainly one of the most capital-intensive — even if dwarfed in size by other segments such as its pharmaceutical counterpart — this farsighted statement begs the question, “Would saying value has already emerged as a major new currency within the U.S. medical imaging market be too much of an overstatement?”
In an era of healthcare reform and a push to meet appropriate use guidelines for tests, imaging and therapy amid declining reimbursements, there has been much discussion about implementation of clinical decision support (CDS) software. There is apprehension by some physicians who view CDS as technology telling doctors how to practice medicine. There are others in healthcare who are concerned about adding cost with the implementation of this software and how it will be updated based on the most current clinical data and practice guidelines. However, if implemented in a way where it is integrated with workflow and accepted by the physicians and hospital leadership, CDS has helped some hospitals meet appropriate use criteria and reduce unnecessary tests, which in turn helped reduce healthcare costs.